165 related articles for article (PubMed ID: 16524432)
1. Determination of eumelanin in human urine.
Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
[TBL] [Abstract][Full Text] [Related]
2. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
[TBL] [Abstract][Full Text] [Related]
3. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
[TBL] [Abstract][Full Text] [Related]
4. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
Wakamatsu K; Yokochi M; Naito A; Kageshita T; Ito S
Melanoma Res; 2003 Aug; 13(4):357-63. PubMed ID: 12883361
[TBL] [Abstract][Full Text] [Related]
5. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography.
Ito S; Fujita K
Anal Biochem; 1985 Feb; 144(2):527-36. PubMed ID: 3993914
[TBL] [Abstract][Full Text] [Related]
6. Melanins in IGR 1 melanoma cells.
Odh G; Hindemith A; Carstam R; Paulson J; Rosengren E; Rorsman H
Pigment Cell Res; 1994 Dec; 7(6):419-27. PubMed ID: 7761350
[TBL] [Abstract][Full Text] [Related]
7. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
Pavel S; Muskiet FA
Cancer Detect Prev; 1983; 6(1-2):311-6. PubMed ID: 6883388
[TBL] [Abstract][Full Text] [Related]
8. HPLC analysis of pheomelanin degradation products in human urine.
Takasaki A; Nezirević D; Arstrand K; Wakamatsu K; Ito S; Kågedal B
Pigment Cell Res; 2003 Oct; 16(5):480-6. PubMed ID: 12950724
[TBL] [Abstract][Full Text] [Related]
9. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma.
Hara H; Walsh N; Yamada K; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):501-5. PubMed ID: 8151128
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of melanin-related metabolites as markers of melanoma progression.
Horikoshi T; Ito S; Wakamatsu K; Onodera H; Eguchi H
Cancer; 1994 Feb; 73(3):629-36. PubMed ID: 8299084
[TBL] [Abstract][Full Text] [Related]
11. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
Wakamatsu K; Ito S
Pigment Cell Res; 2006 Oct; 19(5):460-4. PubMed ID: 16965276
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of eumelanin and pheomelanin in hair and melanomas.
Ito S; Jimbow K
J Invest Dermatol; 1983 Apr; 80(4):268-72. PubMed ID: 6833784
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
Meyerhöffer S; Lindberg Z; Häger A; Kågedal B; Rosdahl I
Acta Derm Venereol; 1998 Jan; 78(1):31-5. PubMed ID: 9498023
[TBL] [Abstract][Full Text] [Related]
15. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
Ito S; Wakamatsu K; Inoue S; Fujita K
Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
[TBL] [Abstract][Full Text] [Related]
16. Eumelanin-related indolic compounds in the urine of treated melanoma patients.
Pavel S; Elzinga H; Muskiet FA; Smit JM; Mulder NH; Koops HS
J Clin Chem Clin Biochem; 1986 Mar; 24(3):167-73. PubMed ID: 3711799
[TBL] [Abstract][Full Text] [Related]
17. The value of cysteinyldopa in the follow-up of disseminated malignant melanoma.
Kärnell R; Kågedal B; Lindholm C; Nilsson B; Arstrand K; Ringborg U
Melanoma Res; 2000 Aug; 10(4):363-9. PubMed ID: 10985671
[TBL] [Abstract][Full Text] [Related]
18. Improved HPLC Conditions to Determine Eumelanin and Pheomelanin Contents in Biological Samples Using an Ion Pair Reagent.
Ito S; Del Bino S; Hirobe T; Wakamatsu K
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698502
[TBL] [Abstract][Full Text] [Related]
19. Pheomelanin-related benzothiazole isomers in the urine of patients with diffuse melanosis of melanoma.
Nezirević Dernroth D; Arstrand K; Greco G; Panzella L; Napolitano A; Kågedal B
Clin Chim Acta; 2010 Sep; 411(17-18):1195-203. PubMed ID: 20420819
[TBL] [Abstract][Full Text] [Related]
20. Trichochromes in the urine of melanoma patients.
Agrup G; Lindbladh C; Prota G; Rorsman H; Rosengren AM; Rosengren E
J Invest Dermatol; 1978 Feb; 70(2):90-1. PubMed ID: 621413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
